Quest Diagnostics Snags Thermo Fisher’s Neuro Testing Lab Biz For $740 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Thermo Fisher Scientific is selling two diagnostic services units, including its Athena Diagnostics neurology testing business, for a total of $940 million, the company announced Feb. 24.